Manufacturers and distributors of medical products increasingly in the focus of the competition authorities
by Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt and Stephan Manuel Nagel, LL.M. (EUI)
COVID-19 and antitrust – a Polish perspective
State aid for companies in the Corona Crisis – what must be considered?
Court of Appeal Judgment confirms that Pfizer and Flynn should not yet be fined for excessive pricing of anti-epilepsy drug
by Paolo Palmigiano and Louisa Penny
Franchise & Distribution Newsletter n°22
France
by multiple authors
Franchise & Distribution Newsletter n°22
by multiple authors
Reform of the investment screening regime 2020
Joint stock companies and ltd joint-stock partnerships to publish announcements on websites
by Marcin Skiba
Franchise & Distribution Newsletter N°21 - 4th Quarter 2019
The EU Market Surveillance Regulation
Safety first!
Competition law and data protection
by Dr. Stefan Horn, LL.B. and Dr. David Klein, LL.M. (Univ. of Washington), CIPP/E
Franchise & Distribution Networks Newsletter N°20 - 3rd Quarter 2019